Nautilus Biotechnology, Inc.
US ˙ NasdaqGS ˙ US63909J1088

SecurityNAUT / Nautilus Biotechnology, Inc.
InsiderSujal M Patel
This page shows the track record and history of Patel Sujal M insider trades in Nautilus Biotechnology, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Sujal M Patel in NAUT / Nautilus Biotechnology, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-09-08 83,500 0.6830 83,500 0.6830 57,030 0 0.7010 1,504 2.64
2025-09-05 116,500 0.6742 116,500 0.6742 78,544
2025-03-20 23,933 0.9982 23,933 0.9982 23,890
2025-03-19 53,300 0.9949 53,300 0.9949 53,028
2024-03-11 12,044 2.8409 12,044 2.8409 34,216
2024-03-08 2,430 2.9885 2,430 2.9885 7,262
2024-03-07 18,854 2.8866 18,854 2.8866 54,424
2024-03-06 9,267 2.7014 9,267 2.7014 25,034
2024-03-05 7,405 2.6464 7,405 2.6464 19,597
2022-08-08 8,346 2.9288 8,346 2.9288 24,444
2022-08-05 41,654 2.9204 41,654 2.9204 121,646
2022-05-09 50,000 3.9600 50,000 3.9600 198,000
2022-03-03 50,000 3.5978 50,000 3.5978 179,890
2021-12-01 88,022 4.7306 88,022 4.7306 416,397
2021-11-30 161,978 4.7215 161,978 4.7215 764,779

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NAUT / Nautilus Biotechnology, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Sujal M Patel in NAUT / Nautilus Biotechnology, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NAUT / Nautilus Biotechnology, Inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2025-09-09 2025-09-08 4 Patel Sujal M NAUT Common Stock P - Purchase D 0.6830 83,500 57 10,341,721
2025-09-09 2025-09-05 4 Patel Sujal M NAUT Common Stock P - Purchase D 0.6742 116,500 79 10,258,221
2025-03-21 2025-03-20 4 Patel Sujal M NAUT Common Stock P - Purchase D 0.9982 23,933 24 10,141,721
2025-03-21 2025-03-19 4 Patel Sujal M NAUT Common Stock P - Purchase D 0.9949 53,300 53 10,117,788
2024-03-11 2024-03-11 4 Patel Sujal M NAUT Common Stock P - Purchase D 2.8409 12,044 34 10,064,488
2024-03-11 2024-03-08 4 Patel Sujal M NAUT Common Stock P - Purchase D 2.9885 2,430 7 10,052,444
2024-03-07 2024-03-07 4 Patel Sujal M NAUT Common Stock P - Purchase D 2.8866 18,854 54 10,050,014
2024-03-07 2024-03-06 4 Patel Sujal M NAUT Common Stock P - Purchase D 2.7014 9,267 25 10,031,160
2024-03-07 2024-03-05 4 Patel Sujal M NAUT Common Stock P - Purchase D 2.6464 7,405 20 10,021,893
2022-08-08 2022-08-08 4 Patel Sujal M NAUT Common Stock P - Purchase D 2.9288 8,346 24 10,014,488
2022-08-08 2022-08-05 4 Patel Sujal M NAUT Common Stock P - Purchase D 2.9204 41,654 122 10,006,142
2022-05-10 2022-05-09 4 Patel Sujal M NAUT Common Stock P - Purchase D 3.9600 50,000 198 9,964,488
2022-03-04 2022-03-04 4 Patel Sujal M NAUT Common Stock M - Exercise D 10.0000 100 1 9,914,488
2022-03-04 2022-03-03 4 Patel Sujal M NAUT Stock Option (Right to Buy) M - Exercise D 10.00 -100 788,733
2022-03-04 2022-03-03 4 Patel Sujal M NAUT Common Stock P - Purchase D 3.5978 50,000 180 9,914,388
2022-02-25 2022-02-25 4 Patel Sujal M NAUT Stock Option (Right to Buy) A - Award D 3.78 400,000 400,000
2021-12-02 2021-12-01 4 Patel Sujal M NAUT Common Stock P - Purchase D 4.7306 88,022 416 9,864,388
2021-12-02 2021-11-30 4 Patel Sujal M NAUT Common Stock P - Purchase D 4.7215 161,978 765 9,776,366
2021-06-09 3 Patel Sujal M NAUT Common Stock D 9,614,388
2021-06-09 3 Patel Sujal M By PFV I, LLC NAUT Common Stock I 5,280,476
2021-06-09 3 Patel Sujal M By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 NAUT Common Stock I 1,814,035
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)